Author claims Quince Therapeutics (QNCX) will 5x within a month on upcoming Phase 3 topline results, framing it as a favorable risk/reward bet.
QNCX — LONG The author argues QNCX is a great buy now because topline results from its 'one of a kind' Phase 3 trial are expected within the next month. They claim the stock, currently around $3.05, could rise to $15-20 following those results, implying a potential 5x return. The author frames this as a very good risk/reward ratio but cautions against going all in. The main stated risk is the binary nature of the trial outcome, though the author does not detail specific downside scenarios.
Wanting to at least 5x your money?
This stock will do just that over the next month with topline results expected for their one of a kind phase 3 trial. currently 3.05 a share with potential to go up between 15-20 following their results.
This Reddit post, published January 15, 2026, features u/Such_Ordinary4737 discussing QNCX. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Such_Ordinary4737 · Tickers: QNCX